Ken'ichi Igano

Title: Ken'ichi Igano: Innovator in Medical Diagnostics

Introduction

Ken'ichi Igano is a notable inventor based in Nara, Japan. He has made significant contributions to the field of medical diagnostics, particularly through his innovative patents. With a total of 2 patents, his work has had a profound impact on the diagnosis of various health conditions.

Latest Patents

One of Ken'ichi Igano's latest patents is a monoclonal antibody recognizing the C-terminus of human brain natriuretic peptide (hBNP). This invention involves cultivating a hybridoma in a medium or the abdominal cavity of a mouse to recover the monoclonal antibody. The resulting immunoassay for hBNP is highly sensitive, with a minimum detection limit of 1 pg/ml. This allows for direct determination of hBNP levels in blood plasma, which is crucial for diagnosing diseases such as hypertension and conditions related to the heart and kidneys. Another significant patent involves tyrosylated proinsulin C-peptide derivatives, which further showcases his innovative approach to medical research.

Career Highlights

Throughout his career, Ken'ichi Igano has worked with prominent companies, including Shionogi Seiyaku Kabushiki Kaisha and Shionogi Company Limited. His experience in these organizations has contributed to his expertise in the field of medical diagnostics and innovation.

Collaborations

Ken'ichi has collaborated with notable colleagues, including Ken Inouye and Masao Kono. These partnerships have likely enriched his research and development efforts, leading to groundbreaking advancements in medical technology.

Conclusion

Ken'ichi Igano's contributions to medical diagnostics through his patents demonstrate his commitment to improving healthcare. His innovative work continues to influence the field and offers valuable tools for diagnosing critical health conditions.